Fgl2: link between hepatitis B and SARS?

A new clotting factor protein, FGL2/fibroleukin, has been found to be important in viral infection, including hepatitis B. A greater understanding of this protein could offer a novel method for intervention and treatment for patients with viral hepatitis.

Detalles Bibliográficos
Autor principal: Robertson, Morag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd. 2003
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129602/
https://www.ncbi.nlm.nih.gov/pubmed/12946632
http://dx.doi.org/10.1016/S1359-6446(03)02836-8
_version_ 1783516822831628288
author Robertson, Morag
author_facet Robertson, Morag
author_sort Robertson, Morag
collection PubMed
description A new clotting factor protein, FGL2/fibroleukin, has been found to be important in viral infection, including hepatitis B. A greater understanding of this protein could offer a novel method for intervention and treatment for patients with viral hepatitis.
format Online
Article
Text
id pubmed-7129602
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Elsevier Science Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71296022020-04-08 Fgl2: link between hepatitis B and SARS? Robertson, Morag Drug Discov Today Update A new clotting factor protein, FGL2/fibroleukin, has been found to be important in viral infection, including hepatitis B. A greater understanding of this protein could offer a novel method for intervention and treatment for patients with viral hepatitis. Elsevier Science Ltd. 2003-09-01 2003-08-22 /pmc/articles/PMC7129602/ /pubmed/12946632 http://dx.doi.org/10.1016/S1359-6446(03)02836-8 Text en Copyright © 2003 Elsevier Science Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Update
Robertson, Morag
Fgl2: link between hepatitis B and SARS?
title Fgl2: link between hepatitis B and SARS?
title_full Fgl2: link between hepatitis B and SARS?
title_fullStr Fgl2: link between hepatitis B and SARS?
title_full_unstemmed Fgl2: link between hepatitis B and SARS?
title_short Fgl2: link between hepatitis B and SARS?
title_sort fgl2: link between hepatitis b and sars?
topic Update
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129602/
https://www.ncbi.nlm.nih.gov/pubmed/12946632
http://dx.doi.org/10.1016/S1359-6446(03)02836-8
work_keys_str_mv AT robertsonmorag fgl2linkbetweenhepatitisbandsars

Ejemplares similares